Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023

List of Tables

The Global Theranostics Market size is expected to reach $5.4 billion by 2030, rising at a market growth of 15.2% CAGR during the forecast period.

North America boasts a well-developed healthcare infrastructure with modern hospitals, diagnostic centers, and research institutions with state-of-the-art medical technologies. Therefore, the North America region captured $782.9 million revenue in the market in 2022. The availability of advanced diagnostic imaging modalities, molecular diagnostic laboratories, and therapeutic facilities enables the adoption and integration of theranostic approaches into clinical practice.

Targeted therapies align with the principles of precision medicine, which emphasize the customization of healthcare interventions based on individual patient characteristics, including genetic makeup, biomarker expression profiles, and disease phenotypes. Targeting specific molecular alterations or disease pathways, targeted therapies offer personalized treatment strategies tailored to individual patient's unique genetic and molecular profiles. Therefore, innovation in targeted therapies is propelling the growth of the market.

Additionally, radiopharmaceuticals possess dual capabilities for diagnostic imaging and targeted therapy, making them ideal candidates for theranostic applications. Radiopharmaceuticals can be labeled with radioactive isotopes that emit gamma rays for diagnostic imaging (e.g., positron emission tomography or single-photon emission computed tomography) and beta particles for therapeutic purposes (e.g., radioimmunotherapy or targeted radionuclide therapy). Hence, rapid growth in radiopharmaceuticals is driving the growth of the market.

However, theranostic approaches often involve integrating sophisticated technologies, including molecular diagnostics, imaging modalities, targeted therapies, and drug delivery systems. Developing and implementing these technologies require specialized expertise in multiple disciplines, such as biology, chemistry, physics, and engineering. Hence, technical complexity hampers the growth of the market.

During the initial stages of the pandemic, healthcare resources and priorities shifted towards managing and controlling the spread of COVID-19. This diversion of resources and focus away from non-urgent medical procedures, including diagnostic imaging and personalized medicine initiatives, temporarily slowed the adoption and implementation of theranostic technologies in clinical practice. Also, the COVID-19 pandemic disrupted global supply chains, affecting the availability and distribution of theranostic products, components, and raw materials. Therefore, the COVID-19 pandemic had a negative impact on the market.

By End User Analysis

Based on end user, the market is categorized into hospitals & cancer care centers, theranostics centers, and research & academic centers. In 2022, the hospitals & cancer care centers segment registered 50.3% revenue share in the market. Hospitals and cancer care centers serve as hubs for comprehensive healthcare services, offering various diagnostic, therapeutic, and supportive care options for patients with complex medical conditions like cancer.

By Product Analysis

Based on product, the market is divided into diagnostic imaging, radiopharmaceuticals, IVD/biomarker screening, and software & services. In 2022, the diagnostic imaging segment garnered 30.5% revenue share in the market. Diagnostic imaging provides valuable treatment planning and guidance information by visualizing disease extent, localization, and staging.

By Application Analysis

On the basis of application, the market is segmented into prostate cancer, bone metastasis, other cancers, and others. The prostate cancer segment recorded 38.1% revenue share in the market in 2022. Prostate cancer exhibits significant heterogeneity in terms of disease aggressiveness, treatment response, and patient outcomes. Theranostic approaches allow for personalizing treatment strategies based on individual patient characteristics and tumor biology.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region generated 23.0% revenue share in the market. The Asia Pacific region is experiencing a rising burden of chronic diseases, including cancer, cardiovascular diseases, and metabolic disorders, due to aging populations, urbanization, and changing lifestyles.

List of Key Companies Profiled

Bayer AG
GE HealthCare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cardinal Health, Inc.
Canon, Inc.
Clarity Pharmaceuticals Ltd
Koninklijke Philips N.V.
Thermo Fisher Scientific, Inc.
Telix Pharmaceuticals Limited
ABX advanced biochemical compounds GmbH

Global Theranostics Market Report Segmentation

By End User

Hospitals & Cancer Care Centers
Theranostics Centers
Research & Academic Centers

By Product

Radiopharmaceuticals
Diagnostic Imaging
IVD/Biomarker Screening
Software & Services

By Application

Prostate Cancer
Bone Metastasis
Other Cancers
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Global Theranostics Market, by End User
- 1.4.2Global Theranostics Market, by Product
- 1.4.3Global Theranostics Market, by Application
- 1.4.4Global Theranostics Market, by Geography
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Global Theranostics Market by End User

4.1Global Hospitals & Cancer Care Centers Market by Region
4.2Global Theranostics Centers Market by Region
4.3Global Research & Academic Centers Market by Region

Chapter 5.Global Theranostics Market by Product

5.1Global Radiopharmaceuticals Market by Region
5.2Global Diagnostic Imaging Market by Region
5.3Global IVD/Biomarker Screening Market by Region
5.4Global Software & Services Market by Region

Chapter 6.Global Theranostics Market by Application

6.1Global Prostate Cancer Market by Region
6.2Global Bone Metastasis Market by Region
6.3Global Other Cancers Market by Region
6.4Global Others Market by Region

Chapter 7.Global Theranostics Market by Region

7.1North America Theranostics Market
- 7.1.1North America Theranostics Market by End User
  - 7.1.1.1North America Hospitals & Cancer Care Centers Market by Country
  - 7.1.1.2North America Theranostics Centers Market by Country
  - 7.1.1.3North America Research & Academic Centers Market by Country
- 7.1.2North America Theranostics Market by Product
  - 7.1.2.1North America Radiopharmaceuticals Market by Country
  - 7.1.2.2North America Diagnostic Imaging Market by Country
  - 7.1.2.3North America IVD/Biomarker Screening Market by Country
  - 7.1.2.4North America Software & Services Market by Country
- 7.1.3North America Theranostics Market by Application
  - 7.1.3.1North America Prostate Cancer Market by Country
  - 7.1.3.2North America Bone Metastasis Market by Country
  - 7.1.3.3North America Other Cancers Market by Country
  - 7.1.3.4North America Others Market by Country
- 7.1.4North America Theranostics Market by Country
  - 7.1.4.1US Theranostics Market
    - 7.1.4.1.1US Theranostics Market by End User
    - 7.1.4.1.2US Theranostics Market by Product
    - 7.1.4.1.3US Theranostics Market by Application
  - 7.1.4.2Canada Theranostics Market
    - 7.1.4.2.1Canada Theranostics Market by End User
    - 7.1.4.2.2Canada Theranostics Market by Product
    - 7.1.4.2.3Canada Theranostics Market by Application
  - 7.1.4.3Mexico Theranostics Market
    - 7.1.4.3.1Mexico Theranostics Market by End User
    - 7.1.4.3.2Mexico Theranostics Market by Product
    - 7.1.4.3.3Mexico Theranostics Market by Application
  - 7.1.4.4Rest of North America Theranostics Market
    - 7.1.4.4.1Rest of North America Theranostics Market by End User
    - 7.1.4.4.2Rest of North America Theranostics Market by Product
    - 7.1.4.4.3Rest of North America Theranostics Market by Application
7.2Europe Theranostics Market
- 7.2.1Europe Theranostics Market by End User
  - 7.2.1.1Europe Hospitals & Cancer Care Centers Market by Country
  - 7.2.1.2Europe Theranostics Centers Market by Country
  - 7.2.1.3Europe Research & Academic Centers Market by Country
- 7.2.2Europe Theranostics Market by Product
  - 7.2.2.1Europe Radiopharmaceuticals Market by Country
  - 7.2.2.2Europe Diagnostic Imaging Market by Country
  - 7.2.2.3Europe IVD/Biomarker Screening Market by Country
  - 7.2.2.4Europe Software & Services Market by Country
- 7.2.3Europe Theranostics Market by Application
  - 7.2.3.1Europe Prostate Cancer Market by Country
  - 7.2.3.2Europe Bone Metastasis Market by Country
  - 7.2.3.3Europe Other Cancers Market by Country
  - 7.2.3.4Europe Others Market by Country
- 7.2.4Europe Theranostics Market by Country
  - 7.2.4.1Germany Theranostics Market
    - 7.2.4.1.1Germany Theranostics Market by End User
    - 7.2.4.1.2Germany Theranostics Market by Product
    - 7.2.4.1.3Germany Theranostics Market by Application
  - 7.2.4.2UK Theranostics Market
    - 7.2.4.2.1UK Theranostics Market by End User
    - 7.2.4.2.2UK Theranostics Market by Product
    - 7.2.4.2.3UK Theranostics Market by Application
  - 7.2.4.3France Theranostics Market
    - 7.2.4.3.1France Theranostics Market by End User
    - 7.2.4.3.2France Theranostics Market by Product
    - 7.2.4.3.3France Theranostics Market by Application
  - 7.2.4.4Russia Theranostics Market
    - 7.2.4.4.1Russia Theranostics Market by End User
    - 7.2.4.4.2Russia Theranostics Market by Product
    - 7.2.4.4.3Russia Theranostics Market by Application
  - 7.2.4.5Spain Theranostics Market
    - 7.2.4.5.1Spain Theranostics Market by End User
    - 7.2.4.5.2Spain Theranostics Market by Product
    - 7.2.4.5.3Spain Theranostics Market by Application
  - 7.2.4.6Italy Theranostics Market
    - 7.2.4.6.1Italy Theranostics Market by End User
    - 7.2.4.6.2Italy Theranostics Market by Product
    - 7.2.4.6.3Italy Theranostics Market by Application
  - 7.2.4.7Rest of Europe Theranostics Market
    - 7.2.4.7.1Rest of Europe Theranostics Market by End User
    - 7.2.4.7.2Rest of Europe Theranostics Market by Product
    - 7.2.4.7.3Rest of Europe Theranostics Market by Application
7.3Asia Pacific Theranostics Market
- 7.3.1Asia Pacific Theranostics Market by End User
  - 7.3.1.1Asia Pacific Hospitals & Cancer Care Centers Market by Country
  - 7.3.1.2Asia Pacific Theranostics Centers Market by Country
  - 7.3.1.3Asia Pacific Research & Academic Centers Market by Country
- 7.3.2Asia Pacific Theranostics Market by Product
  - 7.3.2.1Asia Pacific Radiopharmaceuticals Market by Country
  - 7.3.2.2Asia Pacific Diagnostic Imaging Market by Country
  - 7.3.2.3Asia Pacific IVD/Biomarker Screening Market by Country
  - 7.3.2.4Asia Pacific Software & Services Market by Country
- 7.3.3Asia Pacific Theranostics Market by Application
  - 7.3.3.1Asia Pacific Prostate Cancer Market by Country
  - 7.3.3.2Asia Pacific Bone Metastasis Market by Country
  - 7.3.3.3Asia Pacific Other Cancers Market by Country
  - 7.3.3.4Asia Pacific Others Market by Country
- 7.3.4Asia Pacific Theranostics Market by Country
  - 7.3.4.1China Theranostics Market
    - 7.3.4.1.1China Theranostics Market by End User
    - 7.3.4.1.2China Theranostics Market by Product
    - 7.3.4.1.3China Theranostics Market by Application
  - 7.3.4.2Japan Theranostics Market
    - 7.3.4.2.1Japan Theranostics Market by End User
    - 7.3.4.2.2Japan Theranostics Market by Product
    - 7.3.4.2.3Japan Theranostics Market by Application
  - 7.3.4.3India Theranostics Market
    - 7.3.4.3.1India Theranostics Market by End User
    - 7.3.4.3.2India Theranostics Market by Product
    - 7.3.4.3.3India Theranostics Market by Application
  - 7.3.4.4South Korea Theranostics Market
    - 7.3.4.4.1South Korea Theranostics Market by End User
    - 7.3.4.4.2South Korea Theranostics Market by Product
    - 7.3.4.4.3South Korea Theranostics Market by Application
  - 7.3.4.5Singapore Theranostics Market
    - 7.3.4.5.1Singapore Theranostics Market by End User
    - 7.3.4.5.2Singapore Theranostics Market by Product
    - 7.3.4.5.3Singapore Theranostics Market by Application
  - 7.3.4.6Malaysia Theranostics Market
    - 7.3.4.6.1Malaysia Theranostics Market by End User
    - 7.3.4.6.2Malaysia Theranostics Market by Product
    - 7.3.4.6.3Malaysia Theranostics Market by Application
  - 7.3.4.7Rest of Asia Pacific Theranostics Market
    - 7.3.4.7.1Rest of Asia Pacific Theranostics Market by End User
    - 7.3.4.7.2Rest of Asia Pacific Theranostics Market by Product
    - 7.3.4.7.3Rest of Asia Pacific Theranostics Market by Application
7.4LAMEA Theranostics Market
- 7.4.1LAMEA Theranostics Market by End User
  - 7.4.1.1LAMEA Hospitals & Cancer Care Centers Market by Country
  - 7.4.1.2LAMEA Theranostics Centers Market by Country
  - 7.4.1.3LAMEA Research & Academic Centers Market by Country
- 7.4.2LAMEA Theranostics Market by Product
  - 7.4.2.1LAMEA Radiopharmaceuticals Market by Country
  - 7.4.2.2LAMEA Diagnostic Imaging Market by Country
  - 7.4.2.3LAMEA IVD/Biomarker Screening Market by Country
  - 7.4.2.4LAMEA Software & Services Market by Country
- 7.4.3LAMEA Theranostics Market by Application
  - 7.4.3.1LAMEA Prostate Cancer Market by Country
  - 7.4.3.2LAMEA Bone Metastasis Market by Country
  - 7.4.3.3LAMEA Other Cancers Market by Country
  - 7.4.3.4LAMEA Others Market by Country
- 7.4.4LAMEA Theranostics Market by Country
  - 7.4.4.1Brazil Theranostics Market
    - 7.4.4.1.1Brazil Theranostics Market by End User
    - 7.4.4.1.2Brazil Theranostics Market by Product
    - 7.4.4.1.3Brazil Theranostics Market by Application
  - 7.4.4.2Argentina Theranostics Market
    - 7.4.4.2.1Argentina Theranostics Market by End User
    - 7.4.4.2.2Argentina Theranostics Market by Product
    - 7.4.4.2.3Argentina Theranostics Market by Application
  - 7.4.4.3UAE Theranostics Market
    - 7.4.4.3.1UAE Theranostics Market by End User
    - 7.4.4.3.2UAE Theranostics Market by Product
    - 7.4.4.3.3UAE Theranostics Market by Application
  - 7.4.4.4Saudi Arabia Theranostics Market
    - 7.4.4.4.1Saudi Arabia Theranostics Market by End User
    - 7.4.4.4.2Saudi Arabia Theranostics Market by Product
    - 7.4.4.4.3Saudi Arabia Theranostics Market by Application
  - 7.4.4.5South Africa Theranostics Market
    - 7.4.4.5.1South Africa Theranostics Market by End User
    - 7.4.4.5.2South Africa Theranostics Market by Product
    - 7.4.4.5.3South Africa Theranostics Market by Application
  - 7.4.4.6Nigeria Theranostics Market
    - 7.4.4.6.1Nigeria Theranostics Market by End User
    - 7.4.4.6.2Nigeria Theranostics Market by Product
    - 7.4.4.6.3Nigeria Theranostics Market by Application
  - 7.4.4.7Rest of LAMEA Theranostics Market
    - 7.4.4.7.1Rest of LAMEA Theranostics Market by End User
    - 7.4.4.7.2Rest of LAMEA Theranostics Market by Product
    - 7.4.4.7.3Rest of LAMEA Theranostics Market by Application

Chapter 8.Company Profiles

8.1Bayer AG
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5Recent strategies and developments:
  - 8.1.5.1Acquisition and Mergers:
- 8.1.6SWOT Analysis
8.2GE HealthCare Technologies, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expenses
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Partnerships, Collaborations, and Agreements:
- 8.2.6SWOT Analysis
8.3Siemens Healthineers AG (Siemens AG)
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Product Launches and Product Expansions:
- 8.3.6SWOT Analysis
8.4Cardinal Health, Inc.
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4SWOT Analysis
8.5Canon, Inc.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
8.6Clarity Pharmaceuticals Ltd
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Research & Development Expenses
- 8.6.4SWOT Analysis
8.7Koninklijke Philips N.V.
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Thermo Fisher Scientific, Inc.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expenses
- 8.8.5SWOT Analysis
8.9Telix Pharmaceuticals Limited
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5SWOT Analysis
8.10.ABX advanced biochemical compounds GmbH
- 8.10.1Company Overview
- 8.10.2SWOT Analysis

Chapter 9.Winning Imperatives of Theranostics Market

LIST OF TABLES

TABLE 1Global Theranostics Market, 2019 - 2022, USD Million
TABLE 2Global Theranostics Market, 2023 - 2030, USD Million
TABLE 3Global Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 4Global Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 5Global Hospitals & Cancer Care Centers Market by Region, 2019 - 2022, USD Million
TABLE 6Global Hospitals & Cancer Care Centers Market by Region, 2023 - 2030, USD Million
TABLE 7Global Theranostics Centers Market by Region, 2019 - 2022, USD Million
TABLE 8Global Theranostics Centers Market by Region, 2023 - 2030, USD Million
TABLE 9Global Research & Academic Centers Market by Region, 2019 - 2022, USD Million
TABLE 10Global Research & Academic Centers Market by Region, 2023 - 2030, USD Million
TABLE 11Global Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 12Global Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 13Global Radiopharmaceuticals Market by Region, 2019 - 2022, USD Million
TABLE 14Global Radiopharmaceuticals Market by Region, 2023 - 2030, USD Million
TABLE 15Global Diagnostic Imaging Market by Region, 2019 - 2022, USD Million
TABLE 16Global Diagnostic Imaging Market by Region, 2023 - 2030, USD Million
TABLE 17Global IVD/Biomarker Screening Market by Region, 2019 - 2022, USD Million
TABLE 18Global IVD/Biomarker Screening Market by Region, 2023 - 2030, USD Million
TABLE 19Global Software & Services Market by Region, 2019 - 2022, USD Million
TABLE 20Global Software & Services Market by Region, 2023 - 2030, USD Million
TABLE 21Global Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 22Global Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 23Global Prostate Cancer Market by Region, 2019 - 2022, USD Million
TABLE 24Global Prostate Cancer Market by Region, 2023 - 2030, USD Million
TABLE 25Global Bone Metastasis Market by Region, 2019 - 2022, USD Million
TABLE 26Global Bone Metastasis Market by Region, 2023 - 2030, USD Million
TABLE 27Global Other Cancers Market by Region, 2019 - 2022, USD Million
TABLE 28Global Other Cancers Market by Region, 2023 - 2030, USD Million
TABLE 29Global Others Market by Region, 2019 - 2022, USD Million
TABLE 30Global Others Market by Region, 2023 - 2030, USD Million
TABLE 31Global Theranostics Market by Region, 2019 - 2022, USD Million
TABLE 32Global Theranostics Market by Region, 2023 - 2030, USD Million
TABLE 33North America Theranostics Market, 2019 - 2022, USD Million
TABLE 34North America Theranostics Market, 2023 - 2030, USD Million
TABLE 35North America Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 36North America Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 37North America Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 38North America Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 39North America Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 40North America Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 41North America Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 42North America Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 43North America Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 44North America Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 45North America Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 46North America Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 47North America Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 48North America Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 49North America IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 50North America IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 51North America Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 52North America Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 53North America Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 54North America Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 55North America Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 56North America Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 57North America Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 58North America Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 59North America Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 60North America Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 61North America Others Market by Country, 2019 - 2022, USD Million
TABLE 62North America Others Market by Country, 2023 - 2030, USD Million
TABLE 63North America Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 64North America Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 65US Theranostics Market, 2019 - 2022, USD Million
TABLE 66US Theranostics Market, 2023 - 2030, USD Million
TABLE 67US Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 68US Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 69US Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 70US Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 71US Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 72US Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 73Canada Theranostics Market, 2019 - 2022, USD Million
TABLE 74Canada Theranostics Market, 2023 - 2030, USD Million
TABLE 75Canada Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 76Canada Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 77Canada Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 78Canada Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 79Canada Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 80Canada Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 81Mexico Theranostics Market, 2019 - 2022, USD Million
TABLE 82Mexico Theranostics Market, 2023 - 2030, USD Million
TABLE 83Mexico Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 84Mexico Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 85Mexico Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 86Mexico Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 87Mexico Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 88Mexico Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 89Rest of North America Theranostics Market, 2019 - 2022, USD Million
TABLE 90Rest of North America Theranostics Market, 2023 - 2030, USD Million
TABLE 91Rest of North America Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 92Rest of North America Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 93Rest of North America Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 94Rest of North America Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 95Rest of North America Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 96Rest of North America Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 97Europe Theranostics Market, 2019 - 2022, USD Million
TABLE 98Europe Theranostics Market, 2023 - 2030, USD Million
TABLE 99Europe Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 100Europe Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 101Europe Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 102Europe Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 103Europe Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 104Europe Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 105Europe Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 106Europe Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 107Europe Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 108Europe Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 109Europe Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 110Europe Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 111Europe Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 112Europe Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 113Europe IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 114Europe IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 115Europe Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 116Europe Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 117Europe Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 118Europe Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 119Europe Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 120Europe Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 121Europe Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 122Europe Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 123Europe Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 124Europe Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 125Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 126Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 127Europe Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 128Europe Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 129Germany Theranostics Market, 2019 - 2022, USD Million
TABLE 130Germany Theranostics Market, 2023 - 2030, USD Million
TABLE 131Germany Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 132Germany Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 133Germany Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 134Germany Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 135Germany Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 136Germany Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 137UK Theranostics Market, 2019 - 2022, USD Million
TABLE 138UK Theranostics Market, 2023 - 2030, USD Million
TABLE 139UK Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 140UK Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 141UK Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 142UK Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 143UK Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 144UK Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 145France Theranostics Market, 2019 - 2022, USD Million
TABLE 146France Theranostics Market, 2023 - 2030, USD Million
TABLE 147France Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 148France Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 149France Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 150France Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 151France Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 152France Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 153Russia Theranostics Market, 2019 - 2022, USD Million
TABLE 154Russia Theranostics Market, 2023 - 2030, USD Million
TABLE 155Russia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 156Russia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 157Russia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 158Russia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 159Russia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 160Russia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 161Spain Theranostics Market, 2019 - 2022, USD Million
TABLE 162Spain Theranostics Market, 2023 - 2030, USD Million
TABLE 163Spain Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 164Spain Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 165Spain Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 166Spain Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 167Spain Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 168Spain Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 169Italy Theranostics Market, 2019 - 2022, USD Million
TABLE 170Italy Theranostics Market, 2023 - 2030, USD Million
TABLE 171Italy Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 172Italy Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 173Italy Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 174Italy Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 175Italy Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 176Italy Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 177Rest of Europe Theranostics Market, 2019 - 2022, USD Million
TABLE 178Rest of Europe Theranostics Market, 2023 - 2030, USD Million
TABLE 179Rest of Europe Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 180Rest of Europe Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 181Rest of Europe Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 182Rest of Europe Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 183Rest of Europe Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 184Rest of Europe Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 185Asia Pacific Theranostics Market, 2019 - 2022, USD Million
TABLE 186Asia Pacific Theranostics Market, 2023 - 2030, USD Million
TABLE 187Asia Pacific Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 188Asia Pacific Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 189Asia Pacific Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 190Asia Pacific Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 191Asia Pacific Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 192Asia Pacific Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 193Asia Pacific Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 194Asia Pacific Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 195Asia Pacific Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 196Asia Pacific Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 197Asia Pacific Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 198Asia Pacific Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 199Asia Pacific Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 200Asia Pacific Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 201Asia Pacific IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 202Asia Pacific IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 203Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 204Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 205Asia Pacific Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 206Asia Pacific Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 207Asia Pacific Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 208Asia Pacific Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 209Asia Pacific Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 210Asia Pacific Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 211Asia Pacific Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 212Asia Pacific Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 213Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 214Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 215Asia Pacific Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 216Asia Pacific Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 217China Theranostics Market, 2019 - 2022, USD Million
TABLE 218China Theranostics Market, 2023 - 2030, USD Million
TABLE 219China Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 220China Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 221China Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 222China Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 223China Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 224China Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 225Japan Theranostics Market, 2019 - 2022, USD Million
TABLE 226Japan Theranostics Market, 2023 - 2030, USD Million
TABLE 227Japan Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 228Japan Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 229Japan Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 230Japan Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 231Japan Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 232Japan Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 233India Theranostics Market, 2019 - 2022, USD Million
TABLE 234India Theranostics Market, 2023 - 2030, USD Million
TABLE 235India Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 236India Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 237India Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 238India Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 239India Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 240India Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 241South Korea Theranostics Market, 2019 - 2022, USD Million
TABLE 242South Korea Theranostics Market, 2023 - 2030, USD Million
TABLE 243South Korea Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 244South Korea Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 245South Korea Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 246South Korea Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 247South Korea Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 248South Korea Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 249Singapore Theranostics Market, 2019 - 2022, USD Million
TABLE 250Singapore Theranostics Market, 2023 - 2030, USD Million
TABLE 251Singapore Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 252Singapore Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 253Singapore Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 254Singapore Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 255Singapore Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 256Singapore Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 257Malaysia Theranostics Market, 2019 - 2022, USD Million
TABLE 258Malaysia Theranostics Market, 2023 - 2030, USD Million
TABLE 259Malaysia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 260Malaysia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 261Malaysia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 262Malaysia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 263Malaysia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 264Malaysia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 265Rest of Asia Pacific Theranostics Market, 2019 - 2022, USD Million
TABLE 266Rest of Asia Pacific Theranostics Market, 2023 - 2030, USD Million
TABLE 267Rest of Asia Pacific Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 268Rest of Asia Pacific Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 269Rest of Asia Pacific Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 270Rest of Asia Pacific Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 271Rest of Asia Pacific Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 272Rest of Asia Pacific Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 273LAMEA Theranostics Market, 2019 - 2022, USD Million
TABLE 274LAMEA Theranostics Market, 2023 - 2030, USD Million
TABLE 275LAMEA Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 276LAMEA Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 277LAMEA Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 278LAMEA Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 279LAMEA Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 280LAMEA Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 281LAMEA Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 282LAMEA Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 283LAMEA Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 284LAMEA Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 285LAMEA Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 286LAMEA Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 287LAMEA Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 288LAMEA Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 289LAMEA IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 290LAMEA IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 291LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 292LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 293LAMEA Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 294LAMEA Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 295LAMEA Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 296LAMEA Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 297LAMEA Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 298LAMEA Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 299LAMEA Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 300LAMEA Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 301LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 302LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 303LAMEA Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 304LAMEA Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 305Brazil Theranostics Market, 2019 - 2022, USD Million
TABLE 306Brazil Theranostics Market, 2023 - 2030, USD Million
TABLE 307Brazil Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 308Brazil Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 309Brazil Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 310Brazil Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 311Brazil Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 312Brazil Theranostics Market by Application, 2023 - 2030, USD Million

TABLE 313Argentina Theranostics Market, 2019 - 2022, USD Million
TABLE 314Argentina Theranostics Market, 2023 - 2030, USD Million
TABLE 315Argentina Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 316Argentina Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 317Argentina Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 318Argentina Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 319Argentina Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 320Argentina Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 321UAE Theranostics Market, 2019 - 2022, USD Million
TABLE 322UAE Theranostics Market, 2023 - 2030, USD Million
TABLE 323UAE Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 324UAE Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 325UAE Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 326UAE Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 327UAE Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 328UAE Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 329Saudi Arabia Theranostics Market, 2019 - 2022, USD Million
TABLE 330Saudi Arabia Theranostics Market, 2023 - 2030, USD Million
TABLE 331Saudi Arabia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 332Saudi Arabia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 333Saudi Arabia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 334Saudi Arabia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 335Saudi Arabia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 336Saudi Arabia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 337South Africa Theranostics Market, 2019 - 2022, USD Million
TABLE 338South Africa Theranostics Market, 2023 - 2030, USD Million
TABLE 339South Africa Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 340South Africa Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 341South Africa Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 342South Africa Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 343South Africa Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 344South Africa Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 345Nigeria Theranostics Market, 2019 - 2022, USD Million
TABLE 346Nigeria Theranostics Market, 2023 - 2030, USD Million
TABLE 347Nigeria Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 348Nigeria Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 349Nigeria Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 350Nigeria Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 351Nigeria Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 352Nigeria Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 353Rest of LAMEA Theranostics Market, 2019 - 2022, USD Million
TABLE 354Rest of LAMEA Theranostics Market, 2023 - 2030, USD Million
TABLE 355Rest of LAMEA Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 356Rest of LAMEA Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 357Rest of LAMEA Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 358Rest of LAMEA Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 359Rest of LAMEA Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 360Rest of LAMEA Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 361Key Information - Bayer AG
TABLE 362Key Information - GE HealthCare Technologies, Inc.
TABLE 363Key Information - Siemens Healthineers AG
TABLE 364key information - Cardinal Health, Inc.
TABLE 365Key Information - Canon, Inc.
TABLE 366Key Information - Clarity Pharmaceuticals Ltd
TABLE 367Key Information - Koninklijke Philips N.V.
TABLE 368Key Information - Thermo Fisher Scientific, Inc.
TABLE 369Key Information - Telix Pharmaceuticals Limited
TABLE 370Key Information - ABX advanced biochemical compounds GmbH

Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030

Description

Table of Contents